Talk:Bremelanotide
This is the talk page for discussing improvements to the Bremelanotide article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1 |
![]() | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Bremelanotide.
|
Wiki Education Foundation-supported course assignment
[edit] This article was the subject of a Wiki Education Foundation-supported course assignment, between 3 September 2019 and 12 December 2019. Further details are available on the course page. Student editor(s): Sdavid5304.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 16:14, 16 January 2022 (UTC)
Should Palatin Technologies have it's own article? It just redirects here now for some reason, I guess this their closest product to market. Endercase (talk) 18:14, 6 April 2017 (UTC)
- I kind of doubt whether they are really notable enough to have their own article. but if somebody wants to try, they can find out. Jytdog (talk) 20:10, 6 April 2017 (UTC)
Placebo. Daily sex?
[edit]https://www.livescience.com/65784-how-womens-libido-drug-works.html
- 25% of those who took bremelanotide saw some improvements in their reported sexual desire scores, compared with 17% who took a placebo.
(25-17=8%, so could this medicine be replaced by placebo?)
- Women should not take more than one dose of bremelanotide within a 24-hour period or more than 8 doses per MONTH.
(What if the partner wishes to have sex daily, not 8 times a month?)
--ee1518 (talk) 15:46, 12 August 2019 (UTC)
"Palatin Technologies" listed at Redirects for discussion
[edit]
The redirect Palatin Technologies has been listed at redirects for discussion to determine whether its use and function meets the redirect guidelines. Readers of this page are welcome to comment on this redirect at Wikipedia:Redirects for discussion/Log/2023 December 4 § Palatin Technologies until a consensus is reached. (t · c) buidhe 06:10, 4 December 2023 (UTC)
Start a discussion about improving the Bremelanotide page
Talk pages are where people discuss how to make content on Wikipedia the best that it can be. You can use this page to start a discussion with others about how to improve the "Bremelanotide" page.